Skip to main content
. 2024 Oct 25;14(11):1371. doi: 10.3390/life14111371

Table 5.

Univariate and multivariate Cox proportional hazards model results for relapse.

Relapse
Univariate Analysis Multivariate Analysis
p-Value Hazard Ratio %95 CI p-Value Hazard Ratio %95 CI
Age at Diagnosis 0.585 1.005 0.987–1.023 - - -
Age of Onset of Lesions (Years) 0.615 0.996 0.980–1.012 - - -
Time to Diagnosis (Months) 0.032 * 1.002 1.001–1.005 0.037 * 1.003 1.001–1.005
Gender (Male) 0.474 0.837 0.515–1.361 - - -
Patch/Patch + Plaque (Patch + Plaque) 0.177 0.709 0.431–1.167 - - -
Morphological Findings
Hyperpigmentation (Yes) 0.211 0.691 0.387–1.233 - - -
Erythema (Yes) 0.909 1.030 0.625–1.695 - - -
Pruritus (Yes = 1) 0.515 1.176 0.722–1.914 - - -
Histopathological Findings
Classic 0.270 0.753 0.455–1.246 - - -
Folliculotropism 0.579 1.392 0.433–4.477 - - -
CD8 (+) 0.895 0.957 0.501–1.830 - - -
Stage at Diagnosis
IB 0.281 0.786 0.457–1.351 - - -
IIA 0.518 0.892 0.460–1.733 - - -
T Stage at Diagnosis
(T2)
0.815 0.944 0.583–1.529 - - -
N Stage at Diagnosis
Nx 0.560 0.827 0.483–1.416 - - -
N1 0.492 0.815 0.412–1.613 - - -
β-2 Microglobulin (High) 0.679 0.899 0.541–1.492 - - -
LDH (High) 0.210 2.475 0.599–10.226 - - -
Eosinophilia (Yes) 0.869 0.887 0.214–3.674 - - -
Initial Treatment Type
Skin-directed 0.787 1.098 0.557–2.165 - - -
Combined 0.940 0.974 0.494–1.920 - - -
Initial Treatment
NB-UVB 0.001 * 2.860 1.693–4.831 0.134 1.672 0.853–3.277
PUVA 0.000 * 0.375 0.101–0.628 0.034 * 0.485 0.210–0.947
PUVA + IFN 0.327 1.693 0.729–2.578 - - -

* p < 0.05 significant relationship. p > 0.05 no significant relationship; CI: confidence interval; LDH: lactate dehydrogenase; NB-UVB: Narrowband Ultraviolet B; PUVA: Psoralen + Ultraviolet A; IFN: Interferon.